Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Impressions: 582
https://www.pharmacompass.com/radio-compass-blog/novartis-gsk-sanofi-bms-shell-out-over-us-10-bn-in-dealmaking-as-mid-size-deals-take-centerstage-in-2024
Impressions: 1508
https://www.pharmacompass.com/radio-compass-blog/fda-approvals-slump-19-in-h1-2024-nash-copd-pah-get-new-treatment-options
Impressions: 2493
https://www.pharmacompass.com/radio-compass-blog/fda-s-june-2024-list-of-off-patent-off-exclusivity-drugs-sees-rise-in-cancer-hiv-treatments
Impressions: 2981
https://www.pharmacompass.com/radio-compass-blog/fda-approves-four-oligonucleotide-therapies-in-2023-novartis-gsk-novo-bet-big
Impressions: 2429
https://www.pharmacompass.com/radio-compass-blog/fda-steps-in-to-address-challenges-faced-by-cell-and-gene-therapies
Impressions: 2961
https://www.pharmacompass.com/radio-compass-blog/fda-approvals-rise-49-in-2023-crispr-s-gene-editing-therapy-sees-light-of-day
Impressions: 6855
https://www.pharmacompass.com/radio-compass-blog/job-cuts-double-in-2023-pfizer-bms-novartis-biogen-downsize-to-cut-costs
Impressions: 5386
https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-and-drugs-in-2022-pfizer-breaks-us-100-billion-barrier-abbvie-s-humira-retains-second-spot
Impressions: 8103
https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2021-covid-vaccines-pills-cause-churn-in-list
Impressions: 13450
https://www.pharmacompass.com/radio-compass-blog/top-drugs-and-pharma-companies-by-sales-in-2020
Impressions: 55099
https://www.pharmacompass.com/radio-compass-blog/top-drugs-and-pharmaceutical-companies-of-2019-by-revenues
Impressions: 55099
https://www.pharmacompass.com/radio-compass-blog/top-drugs-and-pharmaceutical-companies-of-2019-by-revenues
Impressions: 13665
https://www.pharmacompass.com/radio-compass-blog/top-15-pharmaceutical-companies-by-drug-sales-in-2016